ebook Munafa Stock Market Course + Intraday & FNO calls  

       

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

Dr. Reddy's Laboratories Ltd Complete list of announcements declared & dividend announcements by Dr. Reddy's Laboratories Ltd RDY

Dr. Reddy's Laboratories Ltd RDY listed on NYSE and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Dr. Reddy's Laboratories Ltd RDY

Dr Reddy's Laboratories launches generic anti-bacterial medication in US
Dr Reddy's Laboratories on Friday said it has launched a generic medication, used to treat a wide variety of bacterial infections, in the US market. The company has launched Doxycycline Capsules (40 mg) in the US market, the Hyderabad-based drug maker said
Announcement as on 03 May 2024

Dr Reddy's launches Doxycycline Capsules in the US
Dr. Reddy's Laboratories announced its launch of Doxycycline Capsules, 40 mg in the U.S. market, a therapeutic generic equivalent of ORACEA (doxycycline, USP) Capsules, 40 mg approved by the U.S. Food and Drug Administration (USFDA).
Announcement as on 03 May 2024

Dr Reddy's launches generic anti-bacterial drug in US
The company's product is a therapeutic generic equivalent of Oracea capsules (40 mg) approved by the US Food and Drug Administration (USFDA).
Announcement as on 03 May 2024

Dr Reddy’s, Sun, Cipla and Biocon look to recreate Ozempic magic in India
Doctors say patients come with specific queries regarding weight-loss drugs, which have become both the first preference and the last resort for some. “I would rather go for these short cuts that the pharma industry offers than go under the knife for my
Announcement as on 27 April 2024

Nestle India, Dr Reddy's to form joint venture for nutraceutical brands
This collaboration aims to expand their complementary nutraceutical portfolios in areas like metabolic care, hospital nutrition, general wellness, women's health, and child nutrition
Announcement as on 25 April 2024

Announcements by Dr. Reddy's Laboratories Ltd first page | Next page | Prev page |

RDY Dr. Reddy's Laboratories Ltd current price & indicator signals

Moving Averages for Dr. Reddy's Laboratories Ltd

  • 5Day Average: 14.7
  • 12Day Average: 13.88
  • 20Day Average: 13.63
  • 50Day Average: 13.51
  • 100Day Average: 13.74
  • 150Day Average: 13.75
  • 200Day Average: 13.85

RDY Indicators & signals

Indicator MACD (12,26,9)

14.16, 13.8, 0.14
Indicator MACD is in positive zone

Indicator ADX (14)

46.15, 54.29, 20
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 63
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of RDY Dr. Reddy's Laboratories Ltd are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
26 Fri Jun 2026 15.38 15.30 to 15.67 0.85% 1.48 times
25 Thu Jun 2026 15.25 14.61 to 15.27 4.02% 1.85 times
24 Wed Jun 2026 14.66 14.20 to 14.66 2.45% 1.25 times
23 Tue Jun 2026 14.31 13.80 to 14.31 2.88% 1.66 times
22 Mon Jun 2026 13.91 13.45 to 14.03 4.67% 1.29 times
18 Thu Jun 2026 13.29 13.20 to 13.36 1.06% 0.8 times
17 Wed Jun 2026 13.15 13.08 to 13.32 -1.13% 1.16 times
16 Tue Jun 2026 13.30 13.23 to 13.38 -0.23% 0.65 times
15 Mon Jun 2026 13.33 13.32 to 13.43 0.23% 0.41 times
12 Fri Jun 2026 13.30 13.30 to 13.40 -0.45% 0.47 times
11 Thu Jun 2026 13.36 13.11 to 13.40 0.45% 0.47 times
10 Wed Jun 2026 13.30 13.27 to 13.47 -0.52% 0.49 times

Videos related to: RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

 

Back to top